Glutamate (Glu) is a major intestinal oxidative fuel, key neurotransmitter, and may be a useful dietary supplement to augment health of the infant gut. We quantified the metabolic fate of various supplemental dietary Glu intakes in young pigs surgically implanted with vascular, intraduodenal (ID), or intragastric (IG) catheters and a portal blood flow probe.
Introduction
The dicarboxylic amino acid glutamate (Glu) is a major oxidative fuel for the gut. In addition, Glu is an important precursor for other biologically active molecules, including glutathione, proline, and arginine, and also functions as a key neurotransmitter (1) (2) (3) . Several studies have shown that Glu is extensively metabolized by the intestinal enterocytes. Seminal findings by Windmueller and Spaeth (4) using in situ perfused rat intestine established that only small fractions of luminally administered Glu are absorbed into the mesenteric venous blood. Our previous studies in infant pigs given [ 13 C]Glu intragastrically (IG) 3 showed that only 5% of [ 13 C]Glu tracer was recovered in the portal circulation compared with 70% of the labeled phenylalanine (2, 5) .
The importance of Glu as a major gut oxidative fuel and key enteric neurotransmitter may have therapeutic potential for improving neonatal gut function. The premature neonatal intestine exhibits a high rate of epithelial growth and cell turnover, but poorly developed gastro-duodenal function limits the ability to provide critically important enteral nutrition (6) . However, the use of Glu as an enteral supplement to augment neonatal gut function should be considered in the context of previous reports of Glu-induced neurotoxicity (7) (8) (9) (10) . Subsequent reviews have concluded that there is no evidence linking monosodium Glu to long-term serious health problems in the general population. These reviews acknowledged the evidence of neurotoxicity in several experimental models, yet this only occurred with extremely high enteral and parenteral Glu loads (11) .
Therefore, the aim of the current study was to examine the capacity of the developing gut to metabolize dietary Glu loads in excess of the normal intake. We undertook the study with 2 protocols utilizing ID and IG routes. The initial study was conducted using the ID route to allow for a more uniform delivery of diet and isotopic tracer to the small intestine. We also completed an IG study to more accurately replicate the typical feeding used in neonatal infants and to evaluate the gastric mucosa as a potential area of Glu absorption and metabolism. In this article, we demonstrate that the gut has a substantial capacity to oxidize and metabolize Glu, even when presented in supraphysiologic amounts. This has implications for further clinical studies investigating the effects of dietary Glu supplementation on neonatal gut development and function.
Materials and Methods

Animals
The following studies used 3-wk-old, female, crossbred piglets (Large White 
ID study
Surgery. At 21 d of age, after overnight food deprivation, piglets were surgically implanted with catheters in the carotid artery, jugular vein, portal vein, and duodenum under general anesthesia, as described previously (12) . Piglets also were implanted with an ultrasonic flow probe (8-10 S model; Transonics) around the portal vein. After surgery, pigs were administered i.v. fluids and nutrients for 24 h as described previously (12) . Pigs were then fed liquid milk replacer formula and recovered for 7 d before starting the infusion protocols.
Infusion protocol 1. This protocol was designed to determine the dosedependent effect of enteral Glu intake on portal Glu and amino acid absorption. The infusion protocol was performed over 8 h. The piglets were randomly assigned to receive 1 of 3 Glu intakes comprising 250, 350, or 400% of their normal Glu intake. The normal Glu intake (100%) was 510 mmolÁkg
21
Áh 21 when the liquid milk formula diet was fed alone. We studied a total of 27 piglets; all pigs received the 100% level first, followed by 1 of 3 higher treatment levels of either 250% (9 pigs), 350% (9 pigs), or 400% (9 pigs) of normal dietary intake. ) of the Glu provided by the formula alone. Portal blood flow (PBF) was measured continuously for the entire 8-h period. Arterial and portal venous blood samples (3 mL) were collected at 2, 3, 4, 6, 7, and 8 h of infusion. We measured the hematocrit of each sample and then centrifuged 1.5 mL of each blood sample at 2000 3 g for 15 min; at 4°C. The resulting plasma was stored at 280°C until amino acid analysis. After the infusion protocol, pigs resumed their normal feeding schedule and 2 d later (d 3) pigs were randomized to another Glu treatment and subjected to the same 8-h infusion protocol again.
Infusion protocol 2. This protocol was designed to quantify the whole body flux and intestinal metabolic fate of a normal (100%) and high (350%) ID Glu load. A total of 9 pigs were assigned to either the normal or high enteral Glu group. All pigs were administered separate infusions of [U- . PBF and blood samples were analyzed as in infusion protocol 1, with the additional analysis of 13 CO 2 as described previously (12) .
IG study
Surgery. Similar to the ID study above, at 21 d of age, piglets were surgically implanted with catheters in the carotid artery, jugular vein, portal vein, and stomach, and a flow probe around the portal vein; postsurgical care and feeding was also similar.
Infusion protocol 3. The aim of this protocol was to quantify the metabolic fate of dietary [U- 13 C]Glu fed IG at 100, 200, and 300% of the normal intake based on the intakes described above. Each pig was randomly assigned to receive 2 of 3 possible Glu intakes (100, 200, or 300%) during a 7-h infusion protocol administered on 2 separate days. At the start of the protocol, pigs were given an oral feeding of 15.5 mL/kg formula followed by a continuous, IG infusion of 7.75 mLÁkg Áh 21 (300% Glu group) for the remaining 5 h of the infusion protocol. A 3-mL arterial blood sample was taken before the start of the enteral feeding and tracer protocol (baseline), then we collected 3-mL arterial and portal blood samples at 5, 6, and 7 h of the [U-
13 C]-Glu infusion. From each sample, we used 1 mL of whole blood to measure hematocrit, hemoglobin, blood gases, and 13 CO 2 enrichment; from the remainder, plasma was obtained and frozen in liquid nitrogen for further analysis. After the infusion protocol, pigs resumed their normal feeding schedule, and 2 d later (d 3), pigs were randomized to another Glu treatment and subjected to the same 7-h infusion protocol again, so that each pig was studied twice.
At the conclusion of d 2 of infusion, pigs were killed with an i.v. injection of pentobarbital sodium (50 mg/kg body weight) and sodium phenytoin (5 mg/kg; Beuthanasia-D; Schering-Plough Animal Health). The abdomen was opened and the entire small intestine distal to the ligament of Treitz, stomach, and liver were quickly removed. The small intestine was immediately flushed with ice-cold saline and tissue samples from the jejunum and ileum were snap-frozen in liquid nitrogen. Concurrently, samples from stomach, liver (left lobe), and brain (cerebrum in anterior temporal lobe and region of hypothalamus) were rapidly dissected and snap-frozen in liquid nitrogen. All tissues were transferred and stored at 280°C until further analysis.
Sample preparation and analysis Blood gasses, hematocrit, and isotopic enrichment (IE) of 13 CO 2 in whole blood were analyzed as previously described (12) . Plasma was obtained from blood after centrifugation (3000 3 g; 10 min at 4°C) and analyzed by HPLC (PicoTag System; Waters) as described previously (13); we determined tissue free amino acid concentrations similarly. The plasma and tissue free isotope enrichment of Glu were measured by GC-MS as described previously (2, 13) . The IE was determined by monitoring ions at mass-to-charge ratio 407 and 412 corresponding to unlabeled Glu (M10) and [U- 13 C]Glu (M15). For each measurement, the baselinecorrected enrichment in mole percent excess (MPE) was determined. Blood 13 CO 2 enrichment was measured as described previously (12) Throughout this article, a positive portal balance signifies the addition of a compound to the portal blood and a negative balance signifies the removal of the compound from the arterial input.
Utilization. Glu utilization refers to the quantity of Glu administered enterally that was not absorbed into the portal blood but utilized by the intestine.
[U-
13
C]Glu utilization was calculated in the same manner.
13 CO 2 production from [
13 C]Glu. 13 CO 2 enrichment was expressed as APE compared with the enrichment in baseline samples taken from each pig before the tracer infusion. The 13 CO 2 production rate by the portaldrained viscera (PDV) was calculated.
Statistical analysis
The mean kinetic measurements of whole body and PDV substrate mass and tracer balance represent mean values derived from analysis of the 3 replicate samples obtained at the end of an infusion protocol. The means for each pig were then used to calculate the mean 6 SEM values in each treatment group. The statistical differences among Glu treatment groups for each infusion protocol were compared using the ANOVA general linear model and then subjected to Tukey's post hoc analysis (Minitab). Differences in arterial and portal concentrations and IE of Glu and other amino acids were tested using a 1-tailed t test. The effect of Glu treatment or intake level on mass and tracer balances were also analyzed by regression. Differences were considered significant at P , 0.05.
Results
ID study
Infusion protocol 1. Neither the body weights nor PBF of the pigs differed among the treatment groups ( Table 1) . Arterial and portal Glu concentrations, the portal-arterial difference, and the net portal Glu absorption and utilization rates all increased dose dependently with increasing dietary Glu infusion. However, when expressed as a percentage of the Glu infusion rate, the fractional net portal balance did not differ among the treatment groups, ranging from ;14 to 19%. Similarly, the fractional net Glu utilization did not differ and ranged from ;86 to 81%.
Infusion protocol 2. The body weights and PBF did not differ in pigs given the 2 tracer infusion modes or enteral Glu infusion rates ( Table 2) . As in infusion protocol 1, the arterial and portal Glu concentrations and the net portal Glu absorption were higher in the 350% group than in the 100% group. Regardless of Glu intake level, during the i.v. [ 13 C]Glu infusions, the [ 13 C]Glu enrichment did not differ between the portal and arterial plasma ( Table 3) . However, during the ID infusions, the [ 13 C]Glu enrichment was higher (P , 0.05) in the portal than arterial plasma. Interestingly, [ 13 C]Glu enrichments in both arterial and portal plasma were higher with 350% compared with 100% Glu intake. The portal 13 (P , 0.05) and the fraction of ID Glu tracer oxidized to 13 CO 2 by the PDV decreased significantly from 49 to 33% in the 350% group compared with the 100% group. Fractional splanchnic extraction of the Glu tracer decreased accordingly from 97 to 88% of tracer intake.
IG study
Infusion protocol 3. The piglet body weights were 9.2, 9.4, and 9.1 kg and the PBF were 3.3, 3.2, and 3.4 LÁkg 21 Áh 21 in the 100, 200, and 300% treatment groups, respectively. Neither differed among the groups. Net portal Glu balances in the 3 treatment groups increased dose dependently (linear effect; P , 0.01) with Glu intake, increasing from 108 to 276 to 545 mmolÁkg 21 Áh 21 at the 100, 200, and 300% intakes, respectively (Fig. 1) ; these balances all differed significantly from one another. In contrast to the results from infusion protocol 1, when expressed as a percentage of Glu intake, the net portal Glu absorption increased from 17 to 21 to 28% with increasing Glu intake (P , 0.05). The net PDV Glu utilization rate increased as well in the 3 treatment groups from 542 to 1024 to 1404 mmolÁkg
21
Áh
21
(P , 0.05). Also in contrast to infusion protocol 1, the fractional PDV utilization rate decreased from 83 to 79 to 72% with increasing Glu intake (P , 0.05) (Fig. 1) (Fig. 2) . The PDV [
13 C]Glu tracer absorption, expressed as percent of the tracer infusion rate, increased from 5 to 13 to 20% (P , 0.05). Importantly, the percentage of the enteral [
13 C]Glu tracer absorbed by the PDV in the 100% intake group was (5%) and similar to that in infusion protocol 2 (3%). Similarly, the percent PDV absorption at 300% intake was nearly identical to that observed at 350% intake in infusion protocol 2 (13.8%). The PDV 13 CO 2 production did not differ among the groups and was 37, 42, and 35% of the 13 C-Glu tracer given in the 100, 200, and 300% treatment groups, respectively (Fig. 2) .
We measured the arterial Glu concentrations in fooddeprived and fed conditions to examine the effect of dietary Glu intake on circulating levels. The arterial plasma Glu concentrations in food-deprived piglets did not differ among the 100% (287 6 22 mmol/L), 200% (281 6 34 mmol/L), and 300% (251 6 26 mmol/L) groups, yet the corresponding fed arterial Glu concentrations increased (P , 0.05) dose dependently (251 6 32, 312 6 38, and 430 6 61 mmol/L) in the 100, 200, and 300% treatment groups, respectively. The plasma arterial Glu differed between fed and food-deprived conditions in the 200 and 300% treatment groups, but not in the 100% group. The relationship between net Glu absorption and dietary intake was estimated in both the ID-(protocol 1) and IG-(protocol 3) fed protocols using linear regression (Fig. 3) . The parameter estimates were significant (P , 0.01) and the estimated slope coefficients were 0.205 for the ID group and 0.339 for the IG group, suggesting that the net Glu absorption rate was higher in the latter.
We quantified several other amino acids that are either metabolites of Glu or are important fuels for the intestine ( Table  4) . The net portal balance of glutamine, aspartate, and ornithine was greater in pigs fed 300% Glu than in those fed 100% Glu. 
1 Values are means 6 SEM, n ¼ 6. *Different from the corresponding 100%, P , 0.05 (ANOVA). 2 All treatment groups were fed the same basal intake of formula. The tracers were infused either i.v. or ID. Body weights did not differ among the groups (6.97 6 1.1 kg), n ¼ 6. 
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The arterial concentrations of aspartate and ornithine in the 300% group were significantly greater than in the 100% treatment group. The net portal absorption of leucine, isoleucine, and valine tended (P , 0.10) to be higher in pigs fed 300% compared with 100% Glu (data not shown).
Tissue free Glu concentrations were measured in stomach, jejunum, ileum, liver, and frontal brain and hypothalamus (data not shown). There was a trend (P , 0.10) toward increased Glu concentrations in the gastrointestinal tissues with increasing Glu intake, but only the concentration in the stomach of the 300% group differed significantly from that of the 100% group. Glu concentrations in the brain and hypothalamus were not increased, even in the 300% treatment group. Tissue free 13 C-Glu enrichment was also measured in blood and tissue samples ( Table 5 ). The [
13 C]Glu enrichments were highest in the stomach and progressively lower in the jejunum and ileum. Consistent with the pattern observed in the arterial plasma, the [ 13 C]Glu enrichments in small intestinal tissue (P , 0.10) to increase with increasing total Glu intake. In liver, MPE in the 200 and 300% groups were significantly greater than in the 100% group. The [ 13 C]Glu enrichments in the brain tissues were low and below the accurate limits of detection (,0.10 MPE) using our GC-MS method.
Discussion
Emerging evidence suggests that Glu plays an important role in gut function serving as a major epithelial cell oxidative fuel and key excitatory neurotransmitter involved in vagal afferent stimulation and nutrient sensing. Dietary Glu supplementation may have particular relevance for the neonatal gut considering the high rate of epithelial turnover and clinical manifestations of poorly developed gastro-duodenal motility in preterm infants. Our previous studies established the ability of the developing gut to metabolize most of the dietary Glu when given in normal dietary amounts (2, 5) . However, because of the potential for neurotoxicity in the developing brain, the extent of intestinal absorption and perturbation of circulating Glu concentration by high dietary loads is an important question to address. The aim of this study was to evaluate the capacity of the developing gut to metabolize enteral Glu loads when given in excess of the normal dietary intake. Our results show that even when the dietary load is 3-to 4-fold the normal level, a majority (70-80%) of the enteral Glu is metabolized by the gut and a large proportion of this is oxidized to CO 2 .
Our results showed that, in absolute terms (i.e. mmolÁkg
21
Áh
21
), the net portal Glu absorption rate increased in a dose-dependent manner with increasing enteral Glu intake. In both the ID and IG infusion protocols, increasing the Glu intake to 300 or 400% resulted in an approximate 4-fold increase in net Glu absorption. The increased portal Glu absorption rates translated into higher circulating arterial Glu concentrations in both the ID and IG infusion protocols. The increased net Glu absorption after IG infusion (protocol 3) at the 200 and 300% intake levels also significantly increased arterial concentrations compared with the fasted level (P , 0.05). Despite the absolute increases in absorption, the fractional Glu absorption rates (expressed percent intake) were not (13 vs. 19% ) changed when the Glu intake increased from 100 to 400%. In the IG protocol, fractional Glu absorption rates significantly increased from 17% in pigs fed the 100% Glu to 28% in pigs fed the 300% Glu (P , 0.05). Thus, Values are means 6 SEM, n ¼ 6. *Different from 100%, P , 0.05 (ANOVA). **Different from arterial IE, P , 0.05 (one-tailed t test). 2 All treatment groups were fed the same basal intake of formula. The tracers were infused either IV or ID. Our study has shown that even when it is administered in higher than normal dietary quantities, the majority of enterally fed Glu is utilized by the gut, mainly as either an oxidative fuel by the mucosa or metabolized into other nonessential amino acids. We also showed that, at high dietary intakes, the fractional rate of Glu absorption is higher when given via the IG compared with ID route. We also found the tissue concentrations of Glu in the brain were unaffected by a demonstrable increase in both intestinal absorption and circulating concentrations of Glu in piglets given high dietary loads of Glu.
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